Val-083 Clinical Trials

Solid Tumor Trials

Solid Tumor Trials

Solid Tumor Trials

A Multi-center Study of VAL-083 in Patients With Recurrent Platinum Resistant Ovarian Cancer

Withdrawn

This is an open label, multi-center, Phase 1/2 clinical trial in subjects with recurrent

A Multi-center Study of VAL-083 in Patients With Recurrent Platinum Resistant Ovarian Cancer (REPROVe): More Information

Enrollment

For more information on enrollment into the current VAL-083 trial, please contact us or visit clinicaltrials.gov for location information.

Contact Us View This Study on ClinicalTrials.gov

The safety and efficacy of the investigational use of this product has not been determined. There is no guarantee that the investigational use listed will be filed with and/or approved for marketing by a regulatory agency.